A COMPARITIVE EVALUATION OF BLOOD SUGAR AND GLYCOSYLATED HEMOGLOBIN IN CLINICALLY MANIFESTED DIABETIC NEUROPATHY

Srinivasa Reddy Dumpa; Gladstone Vijaya V; Natarajan S

Volume : VII, Issue : XI, November - 2018

A COMPARITIVE EVALUATION OF BLOOD SUGAR AND GLYCOSYLATED HEMOGLOBIN IN CLINICALLY MANIFESTED DIABETIC NEUROPATHY

Srinivasa Reddy Dumpa, Gladstone Vijaya V, Natarajan S

Abstract :

Background: Diabetic neuropathy is one of the most common long term complications of diabetes and is clinically present in 30–50%. It is the most common form of neuropathy in the developed countries of world. Also it accounts for 50–70% of non–traumatic amputation. Objective: To compare the efficacy of blood sugar and Glycosylated Hb estimation in predicting the risk of diabetic neuropathy and monitoring the control of diabetes. Method:200 diabetic patients attended Department of General Medicine in Meenakshi Medical College Hospital and Research Institute with symptoms suggestive of diabetic neuropathy were subjected to detailed history for the presence of various risk factors, complete clinical examination and lab investigation including, FBS, PPBS, HbA₁C, and etc. Results: Diabetic neuropathy was common in age group of 56–65 years (34%) with average duration of diabetes mellitus for 11.7 years. Based on Glyco–Hb test, poor glycemic control was reported in 31% of cases and based on blood sugar poor glycemic control was reported among 21% of cases (P=0.0011). Conclusion: Poor glycemic control, a major pathogentic factor for diabetic neuropathy is reflected more often by glycoHb than blood sugar level. Thus glycoHb estimation is superior to conventional method in assessing the risk of and monitoring diabetic neuropathy.